Joel Mases's Avatar

Joel Mases

@jmasesbcn.bsky.social

Segarrenc de Guissona. Radiation Oncologist MD. GU and hepatic cancer at Hospital Clínic. Barcelona. #radonc

155 Followers  |  235 Following  |  1 Posts  |  Joined: 08.01.2024
Posts Following

Posts by Joel Mases (@jmasesbcn.bsky.social)

Rad Onc starter pack, by @morganslevy.bsky.social!

go.bsky.app/TbynCkm

18.11.2024 01:50 — 👍 7    🔁 3    💬 1    📌 0
ScienceDirect.com | Science, health and medical journals, full text articles and books.

Ever wondered if urethral dose explained the differential GU toxicity by platform in PACE-B? It appears not- credit to Dr Ragu Ratnakumaran @ijrobp.bsky.social

eur01.safelinks.protection.outlook.com?url=https%3A...

24.01.2025 16:00 — 👍 17    🔁 6    💬 2    📌 1
Post image

When even the WSJ Editorial Board has this to say
www.wsj.com/opinion/rfk-...

27.01.2025 14:42 — 👍 552    🔁 206    💬 28    📌 19
Post image

Coffee drinking timing and mortality in US adults

"Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

academic.oup.com/eurheartj/ad...

13.01.2025 05:02 — 👍 57    🔁 15    💬 2    📌 11
Preview
Locoregional Therapies for Hepatocellular Carcinoma This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...

Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open

✅Inclusion:
RCTs with PFS and OS as endpoints

✅Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization

#oncsky #radonc #radsky #liversky

ja.ma/3ONRpQ1

06.12.2024 12:45 — 👍 19    🔁 7    💬 3    📌 0

Hi! I’d like to be there! :)

04.12.2024 17:03 — 👍 1    🔁 0    💬 1    📌 0